MedPath

Ghrelin and Diastolic Heart Function

Completed
Conditions
Diabetes Mellitus, Type 2
Obesity, Abdominal
Diastolic Dysfunction
Interventions
Procedure: abdominal plastic intervention
Registration Number
NCT05988346
Lead Sponsor
University of Campania "Luigi Vanvitelli"
Brief Summary

In type 2 diabetes mellitus (T2DM) and obese patients the adipose tissue could over-express cytokines, sirtuin-1 (SIRT1), and microRNAs (miRs) implied in the regulation of left ventricle (LV) diastolic function (LV-DF). Ghrelin could modulate these pathways. Thus, in the current study authors will investigate ghrelin expression in T2DM obese patients after abdominal fat excision, and particularly in those with normalization of LV-DF at 1 year of follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Clinical diagnosis of T2DM obese patients;
  • T2DM obese patients under anti-diabetic full medical therapy and glycemic control.
Exclusion Criteria
  • clinical diagnosis of type 1 diabetes;
  • T2DM patients in poor glycemic control (HbA1c values of >7%);
  • chronic neurological disorders;
  • heart failure and coronary heart disease or depression of left ventricular ejection fraction (LVEF <55%);
  • severe anemia;
  • thyroid dysfunction;
  • kidney failure;
  • uncontrolled blood pressure (blood pressure > 140/90 mmHg on two occasions 2 weeks apart);
  • inflammatory chronic disease;
  • neoplastic disease.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
T2DM obese patients with first degree of left ventricle (LV) diastolic dysfunction.abdominal plastic intervention-
T2DM obese patients with second degree of left ventricle (LV) diastolic dysfunction.abdominal plastic intervention-
type 2 diabetes mellitus (T2DM) obese patients without left ventricle (LV) diastolic dysfunction.abdominal plastic intervention-
Primary Outcome Measures
NameTimeMethod
normalization of LV diastolic dysfunction12 months

At 1 year of follow-up authors evaluated the patients (those with first and second degree of LV diastolic dysfunction) that will experience the normalization of LV diastolic function.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Celestino Sardu

🇮🇹

Naples, Italy

© Copyright 2025. All Rights Reserved by MedPath